MedTrace Logo

Prospective Evaluation of the LithoVue Elite Ureteroscope

NCT04900688 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2024-06-07

No results posted yet for this study

Summary

Flexible ureteroscopy has become the main surgical treatment for kidney stone disease. The procedure uses many types of ureteroscopes (disposable and non-disposable). Currently we are using the LithoVue Single-Use Digital Flexible Ureteroscope. The Health Canada approved LithoVue Elite disposable flexible ureteroscope will now offer novel pressure sensory capacity. In order to evaluate the new ureteroscopy we will be conducting a prospective multi-institution study in order to determine the main features, capacity and abilities of the new scope. We will evaluate the impact of intra renal pressure on pain, quality of life and possible infectious complications.

Conditions

  • Kidney Stone

Interventions

DEVICE

LithoVue Elite

LithoVue Elite is a disposable flexible ureteroscope that offer novel pressure sensory capacity

Sponsors & Collaborators

  • University of British Columbia

    collaborator OTHER

  • Western University, Canada

    collaborator OTHER

  • Université de Montréal

    collaborator OTHER

  • University of Saskatchewan

    collaborator OTHER

  • Laval University

    collaborator OTHER

  • Centre hospitalier de l'Université de Montréal (CHUM)

    lead OTHER

Principal Investigators

  • Naeem Dr Bhojani, MD · Centre hospitalier de l'Université de Montréal (CHUM)

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-16
Primary Completion
2025-03-15
Completion
2025-09-15

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04900688 on ClinicalTrials.gov